Chelation Therapy: Reducing the Root Cause of Disease
Jan 02, 2013 08:41PM
● By
Linda Sechrist
Although chelation therapy was approved by the U.S. Food and Drug Administration in the 1940s for the sole purpose of bonding with toxic metals, more than 1 million individuals have used one form of the therapy, an intravenous injection of ethylenediaminetetraacetic acid (EDTA) for relief from a wide range of circulatory problems.
Read More »
